IBDEI2W7 ; ; 04-FEB-2020
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,46139,2)
 ;;=^5006396
 ;;^UTILITY(U,$J,358.3,46140,0)
 ;;=H43.391^^176^2300^55
 ;;^UTILITY(U,$J,358.3,46140,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,46140,1,3,0)
 ;;=3^Vitreous Opacities,Right Eye NEC
 ;;^UTILITY(U,$J,358.3,46140,1,4,0)
 ;;=4^H43.391
 ;;^UTILITY(U,$J,358.3,46140,2)
 ;;=^5005949
 ;;^UTILITY(U,$J,358.3,46141,0)
 ;;=H43.392^^176^2300^54
 ;;^UTILITY(U,$J,358.3,46141,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,46141,1,3,0)
 ;;=3^Vitreous Opacities,Left Eye NEC
 ;;^UTILITY(U,$J,358.3,46141,1,4,0)
 ;;=4^H43.392
 ;;^UTILITY(U,$J,358.3,46141,2)
 ;;=^5005950
 ;;^UTILITY(U,$J,358.3,46142,0)
 ;;=H02.831^^176^2300^22
 ;;^UTILITY(U,$J,358.3,46142,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,46142,1,3,0)
 ;;=3^Dermatochalasis,Right Upper Eyelid
 ;;^UTILITY(U,$J,358.3,46142,1,4,0)
 ;;=4^H02.831
 ;;^UTILITY(U,$J,358.3,46142,2)
 ;;=^5004418
 ;;^UTILITY(U,$J,358.3,46143,0)
 ;;=H02.834^^176^2300^21
 ;;^UTILITY(U,$J,358.3,46143,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,46143,1,3,0)
 ;;=3^Dermatochalasis,Left Upper Eyelid
 ;;^UTILITY(U,$J,358.3,46143,1,4,0)
 ;;=4^H02.834
 ;;^UTILITY(U,$J,358.3,46143,2)
 ;;=^5004421
 ;;^UTILITY(U,$J,358.3,46144,0)
 ;;=H10.31^^176^2300^14
 ;;^UTILITY(U,$J,358.3,46144,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,46144,1,3,0)
 ;;=3^Conjunctivitis,Acute,Right Eye
 ;;^UTILITY(U,$J,358.3,46144,1,4,0)
 ;;=4^H10.31
 ;;^UTILITY(U,$J,358.3,46144,2)
 ;;=^5133458
 ;;^UTILITY(U,$J,358.3,46145,0)
 ;;=H10.32^^176^2300^13
 ;;^UTILITY(U,$J,358.3,46145,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,46145,1,3,0)
 ;;=3^Conjunctivitis,Acute,Left Eye
 ;;^UTILITY(U,$J,358.3,46145,1,4,0)
 ;;=4^H10.32
 ;;^UTILITY(U,$J,358.3,46145,2)
 ;;=^5133459
 ;;^UTILITY(U,$J,358.3,46146,0)
 ;;=H00.11^^176^2300^12
 ;;^UTILITY(U,$J,358.3,46146,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,46146,1,3,0)
 ;;=3^Chalazion,Right Upper Eyelid
 ;;^UTILITY(U,$J,358.3,46146,1,4,0)
 ;;=4^H00.11
 ;;^UTILITY(U,$J,358.3,46146,2)
 ;;=^5004233
 ;;^UTILITY(U,$J,358.3,46147,0)
 ;;=H00.14^^176^2300^11
 ;;^UTILITY(U,$J,358.3,46147,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,46147,1,3,0)
 ;;=3^Chalazion,Left Upper Eyelid
 ;;^UTILITY(U,$J,358.3,46147,1,4,0)
 ;;=4^H00.14
 ;;^UTILITY(U,$J,358.3,46147,2)
 ;;=^5004236
 ;;^UTILITY(U,$J,358.3,46148,0)
 ;;=H20.00^^176^2300^34
 ;;^UTILITY(U,$J,358.3,46148,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,46148,1,3,0)
 ;;=3^Iridocyclitis,Acute/Subacute,Unspec
 ;;^UTILITY(U,$J,358.3,46148,1,4,0)
 ;;=4^H20.00
 ;;^UTILITY(U,$J,358.3,46148,2)
 ;;=^5005133
 ;;^UTILITY(U,$J,358.3,46149,0)
 ;;=B00.59^^176^2300^32
 ;;^UTILITY(U,$J,358.3,46149,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,46149,1,3,0)
 ;;=3^Herpes Viral Eye Disease NEC
 ;;^UTILITY(U,$J,358.3,46149,1,4,0)
 ;;=4^B00.59
 ;;^UTILITY(U,$J,358.3,46149,2)
 ;;=^5000476
 ;;^UTILITY(U,$J,358.3,46150,0)
 ;;=Z01.00^^176^2300^30
 ;;^UTILITY(U,$J,358.3,46150,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,46150,1,3,0)
 ;;=3^Eye/Vision Exam w/o Abnormal Findings
 ;;^UTILITY(U,$J,358.3,46150,1,4,0)
 ;;=4^Z01.00
 ;;^UTILITY(U,$J,358.3,46150,2)
 ;;=^5062612
 ;;^UTILITY(U,$J,358.3,46151,0)
 ;;=Z01.01^^176^2300^29
 ;;^UTILITY(U,$J,358.3,46151,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,46151,1,3,0)
 ;;=3^Eye/Vision Exam w/ Abnormal Findings
 ;;^UTILITY(U,$J,358.3,46151,1,4,0)
 ;;=4^Z01.01
 ;;^UTILITY(U,$J,358.3,46151,2)
 ;;=^5062613
